Protocol Ledger

NCT05546320 · Phase II · COMPLETED

Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

Interventional Phase II clinical trial protocol NCT05546320 sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-10-15 Enrollment: 1,000 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05546320
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,000 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05546320
Protocol FieldVerified Registry Value
NCT IdentifierNCT05546320
Consolidated Lead SponsorChinese Academy of Medical Sciences, Fuwai Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment1,000 participants (ACTUAL)
Registered Start Date2022-10-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI